TrustCore Financial Services’s Clearside Biomedical CLSD Stock Holding History

TrustCore Financial Services’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,800	Closed	-$74K	–	928
2020 Q4	$74K	Buy	1,800 +1,667	+1,253%	+$43.2K	0.01%	374
2020 Q3	$3K	Hold	133	–	–	﹤0.01%	727
2020 Q2	$4K	Hold	133	–	–	﹤0.01%	726
2020 Q1	$3K	Hold	133	–	–	﹤0.01%	731
2019 Q4	$6K	Hold	133	–	–	﹤0.01%	703
2019 Q3	$1K	Hold	133	–	–	﹤0.01%	896
2019 Q2	$2K	Buy	+133	New	+$2.37K	﹤0.01%	826
2018 Q4	–	Sell	-1,106	Closed	-$102K	–	475
2018 Q3	$102K	Buy	1,106 +134	+14%	+$15.9K	0.03%	212
2018 Q2	$156K	Buy	972 +716	+280%	+$121K	0.06%	167
2018 Q1	$41K	Buy	256 +40	+19%	+$4.87K	0.02%	309
2017 Q4	$23K	Buy	+216	New	+$23.2K	0.01%	375

Other funds holding CLSD

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIIC

AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TrustCore Financial Services's CLSD Position: Q1 2021 in Review

TrustCore Financial Services sold out of Clearside Biomedical (CLSD) in Q1 2021, closing a stake of 1,800 shares — an estimated $74K sold.

TrustCore Financial Services first reported a position in CLSD in Q4 2017 and held it in 11 quarters. The position peaked at $156K in Q2 2018. 51 funds tracked by Wall St. Rank hold CLSD as of Q1 2021.

TrustCore Financial Services reported no remaining Clearside Biomedical position as of Q1 2021 after selling out during the quarter.
TrustCore Financial Services sold 1,800 Clearside Biomedical shares in Q1 2021, an estimated $74K.
TrustCore Financial Services first reported a position in Clearside Biomedical in Q4 2017 and held it in 11 quarters.
TrustCore Financial Services's Clearside Biomedical position peaked at $156K in Q2 2018.
51 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2021.

Based on TrustCore Financial Services's 13F filing for Q1 2021, filed 30 Apr 2021.